Restrictive- vs Individualized Goal Directed Fluid Therapy in Liver Surgery

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
\"Low central venous pressure (low-CVP) or a restrictive fluid administration strategy is usually used worldwide during major liver resection surgery. Although individualized goal directed fluid therapy (GDFT) has been associated with reduced morbidity and mortality in major abdominal surgery, concerns remain on blood loss when applying GDFT in liver surgery. Indeed, GDFT could lead to a higher CVP with the risk of increased blood loss and reduced quality of the surgical field especially during liver dissection. Since evidence is scarce, this randomized controlled trial investigates the impact of a restrictive vs an individualized GDFT strategy assisted by an assisted fluid management (AFM) system on lactate level, blood loss, and postoperative morbidity including acute kidney injury (AKI) in major liver resections.\"
Epistemonikos ID: e2d3859dbe547b4b4f9357260ca77950cbf34c0c
First added on: Feb 19, 2024